1 July 2008 Monitoring of hexyl 5-aminolevulinate-induced photodynamic therapy in rat bladder cancer by optical spectroscopy
Author Affiliations +
Abstract
Monitoring of the tissue response to photodynamic therapy (PDT) can provide important information to help optimize treatment variables such as drug and light dose, and possibly predict treatment outcome. A urinary bladder cancer cell line (AY-27) was used to induce orthotopic transitional cell carcinomas (TCC) in female Fischer rats, and hexyl 5-aminolevulinate (HAL, 8 mM, 1 h)-induced PDT was performed on day 14 after instillation of the cancer cells (20 J/cm2 fluence at 635 nm). In vivo optical reflectance and fluorescence spectra were recorded from bladders before and after laser treatment with a fiberoptic probe. Calculated fluorescence bleaching and oxygen saturation in the bladder wall were examined and correlated to histology results. Reflectance spectra were analyzed using a three-layer optical photon transport model. Animals with TCC treated with PDT showed a clear treatment response; decreased tissue oxygenation and protoporphyrin IX (PpIX) fluorescence photobleaching were observed. Histology demonstrated that 3 of 6 animals with treatment had no sign of the tumor 7 days after PDT treatment. The other 3 animals had significantly reduced the tumor size. The most treatment-responsive animals had the highest PpIX fluorescence prior to light irradiation. Thus, optical spectroscopy can provide useful information for PDT. The model has proved to be very suitable for bladder cancer studies.
© (2008) Society of Photo-Optical Instrumentation Engineers (SPIE)
Eivind L. P. Larsen, Eivind L. P. Larsen, Lise Lyngsnes Randeberg, Lise Lyngsnes Randeberg, Odrun Arna Gederaas, Odrun Arna Gederaas, Carl-Jørgen Arum, Carl-Jørgen Arum, Astrid Hjelde, Astrid Hjelde, Chun-Mei Zhao, Chun-Mei Zhao, Duan Chen, Duan Chen, Hans E. Krokan, Hans E. Krokan, Lars Othar Svaasand, Lars Othar Svaasand, } "Monitoring of hexyl 5-aminolevulinate-induced photodynamic therapy in rat bladder cancer by optical spectroscopy," Journal of Biomedical Optics 13(4), 044031 (1 July 2008). https://doi.org/10.1117/1.2967909 . Submission:
JOURNAL ARTICLE
9 PAGES


SHARE
Back to Top